THE IMPORTANCE OF ANTICOAGULANT THERAPY IN THE RISK AND DEVELOPMENT OF HEMORRHAGIC STROKE IN COVID-19

Authors

  • M. Ataniyazov
  • G. Rakhimbaeva
  • A. Khamidov

Keywords:

Covid-19, SARS-CoV-2, hemorrhagic stroke, activated partial thromboplastin time, D-dimer, fibrinogen, prothrombin time, heparin, enoxiparin, rivaroxaban.

Abstract

This article analyzes the risk and development of hemorrhagic stroke during
anticoagulation therapy in patients with COVID-19, as well as the effect and efficacy of
different anticoagulant agents on hemorheological parameters, and the results after treatment
in the early stages of the disease are presented.

Downloads

Published

2022-11-20

Issue

Vol. 2 No. 6 (2022): British Medical Journal

Section

Articles